The 2020 Lifetime Disruptor is ...
Click Here to Manage Email Alerts
During this year’s ACG 2020 Virtual meeting, Healio hosted its annual Disruptive Innovators Award ceremony.
These awards stem from the disruption that Healio caused in gastroenterology by using a Peer Tested concept to deliver in print what physicians read online. Using analytics, data and social media, what is trending online is delivered to your mailbox. The Healio Disruptive Innovators represent the revolutionary mindset of Healio Gastroenterology.
From social media giants to health equity, these Healio Disruptive Innovators are the ultimate in Peer Tested with more than 1,000 of our readers and followers voting.
Lifetime Disruptor
This award goes to a gastroenterologist or hepatologist who consistently pushed the gastroenterology field forward through innovative treatments, practice management, patient care or research.
The awardee is recognized as a leader in his or her subspecialty and incoming physicians recognize the contributions made to the field. We set the bar high with past winners Carol Burke, MD, and Stephen Hanauer, MD.
This year’s winner is:
Abreu leads the Crohn’s and Colitis fields in her translational research aimed at finding a cure for these inflammatory bowel conditions. Specifically, she is bringing the genetic and environmental factors of IBD development in the Hispanic population into the mainstream conversation.
2019 brought her a Sherman Prize and 2020 started with her direction of another successful Crohn’s and Colitis Congress.
Truly a Lifetime Disruptor, Abreu is quoted on the Sherman Prize site as saying, “Taking care of patients and finding new ways to help them has been my life’s purpose and that’s what inspires my research – the possibility of helping both my patients, as well as those that I’ll never see.”